A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Prostatic HyperplasiaUrinary Bladder, OveractiveErectile Dysfunction

Interventions

DRUG

UK369,003

oral tablet, once a day

DRUG

sildenafil

single oral dose on day 14 or day 17

DRUG

sildenafil matching placebo

single oral dose on day 14 or day 17

Trial Locations (1)

Pfizer Investigational Site, Singapore